Ewan Pearson retweeted
📢 LAST CALL!!!! Applications Closing Soon! The #EFSD and #Lilly European #Diabetes Research Programme is still accepting applications.
📅Deadline: 1 September 2026 | 🕛12:00 hrs CEST
🔗 👉 Apply now: europeandiabetesfoundation.o…
Programme supported by @LillyDiabetesIn.
#Funding
ALT EFSD call for applications for the EFSD and Lilly European Diabetes Research Programme, supporting European diabetes research and raising awareness of the burden of diabetes. Laboratory image is shown and the EFSD logo is shown on the bottom left corner. The europeandiabetesfoundation.org website is shown on the bottom right corner.
We are looking to appoint to 2 consultant D&E posts in Dundee. A great opportunity to move north to cooler climes and join a great clinical and academic team. Spread the word! apply.jobs.scot.nhs.uk/Job/J…
Ewan Pearson retweeted
This is shocking 😮. Just happened at the start of #ADA2026 Scientific Sessions.
Ewan Pearson retweeted
Genome-wide association study in @UK_biobank identifies an interaction between metformin and CUBN gene variant that predisposes to metformin-induced vitamin B12 deficiency in T2D patients. @daniel_f_carr @LivUNIISMIB @dundeeuni @harvardmed link.springer.com/article/10… 🔓
Who measures B12 levels in metformin treated patients? With colleagues from Liverpool We’ve published on a large pharmacogenetic effect - where variants in the cubulin gene increase risk of B12 deficiency @DiabetologiaJnl @dundeeuni link.springer.com/article/10…
The 14% of white population with AA genotype are 2.5 times more likely to require B12 replacement GG. Equates to 10% requiring B12 replacement by 11 years after starting metformin with AA genotype vs 21 years for GG. A large effect!
Ewan Pearson retweeted
To prescribe or not to prescribe? #SGLT2 inhibitors slow #CKD progression but it's unclear who with #T2D and mild/no CKD truly benefits. This new model predicts individual benefit, supporting more targeted prescribing. #PrecisionMedicine link.springer.com/article/10… 🔓@Exeter_Diabetes
Ewan Pearson retweeted
📢 Job Opportunity: @EASDnews is seeking an Editor-in-Chief for its flagship journal, @DiabetologiaJnl.
Lead one of the world’s top #diabetes #research journals.
🔗 Apply now: tinyurl.com/diab-eic-job-ad
🗓️ Closing date: 17 Nov 2025
#Diabetologia #Vacancy #EditorInChief
📢 Applications are open for the next EIC of Diabetologia! More info here tinyurl.com/diab-eic-job-ad
Ewan Pearson retweeted
Metabologia is a new journal from the EASD launched last month, sister journal of @DiabetologiaJnl and open for submissions! Go to metabologia.org/ for more info
Great presentation to a packed hall from Shilpa Garg (PhD student @dundeeuni) at #easd2025 on clinical and genetic predictors of drug response in diabetes
Congratulations Andrew!
🏆It is with great honour that we announce the 57th EASD Claude Bernard Prize recipient, Prof. @athattersley , in recognition of his trailblazing contributions to #diabetes #research and #precisionmedicine.
Congratulations, Prof. Hattersley👏
Supported by @sanofi
@UniofExeter
ALT Announcement graphic for the 61st EASD Annual Meeting, taking place from 15–19 September 2025 in Vienna, Austria. The image has a red background with a white Ferris wheel illustration on the right. A circular photo of Prof. Andrew Hattersley is shown, highlighting him as the recipient of the 57th EASD Claude Bernard Prize. The EASD logo and website (easd.org) appear at the bottom.
Ewan Pearson retweeted
💥Those of us working in science comms are perhaps too fond of the word "gamechanging" but this research by @john_den_ @athattersley @Exeter_Diabetes, published today in @TheLancet and announced at #DUKPC25, truly deserves that description 💥
#Type2Diabetes #BetterCare
This exciting paper will change how most people with type 2 diabetes are managed - predicting individual level
glycaemic response to glucose lowering drugs. Led by @john_den_ and @athattersley at Exeter (with @dundeeuni @UoDMedicine) thelancet.com/journals/lance…
For those at #dukpc2025 #dukpc @diabetesuk @kamleshkhunti Glasgow do come to our session on Thursday at 1115 when we will present this paper and show you how important simple clinical features are to choice of therapy in type 2 diabetes.
And if you happen to live in Tayside and have diabetes the Exeter 5-drug model is now being used in our iDiabetes precision medicine implementation study idiabetes.org.uk/ and bmjopen.bmj.com/content/14/1…
Ewan Pearson retweeted
5-drug precision prescribing for people with type 2 diabetes is here - @TheLancet our @ExeterMedmodel for optimising glucose lowering therapy using low-cost routine clinical features
Paper: thelancet.com/journals/lance…
Web calc: diabetesgenes.org/t2-treatme…
Calling all Endocrinologists. Would you like to move to Scotland? We have an Endocrine focused post with up to 12 PAs in Dundee. apply.jobs.scot.nhs.uk/Decid…
We are a dynamic team with strong links between NHS and Uni. The quality of life here is good - and for the cost of a flat in london you can by a mansion here! Message me or Paul Newey if you’d like to discuss this. @NHSTayside @UoDMedicine
Ewan Pearson retweeted
Nearly 30years after her original diabetes diagnosis Mary had a genetic test identifying she had HNF1A MODY and could stop insulin injections hear from her and @ezpearson in our latest podcast 1in6b.com/series-3-episode-1… @Exeter_Diabetes @UofE_Research @RoyalDevonNHS @athattersley